Protek Capital Stock Price To Sales
| PRPM Stock | USD 0.0001 0.00 0.00% |
Protek Capital fundamentals help investors to digest information that contributes to Protek Capital's financial success or failures. It also enables traders to predict the movement of Protek Pink Sheet. The fundamental analysis module provides a way to measure Protek Capital's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protek Capital pink sheet.
Protek |
Protek Capital Company Price To Sales Analysis
Protek Capital's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Protek Capital Price To Sales | 0.36 X |
Most of Protek Capital's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Protek Capital is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Protek Capital has a Price To Sales of 0.3625 times. This is 92.4% lower than that of the Technology sector and significantly higher than that of the Software—Application industry. The price to sales for all United States stocks is 96.83% higher than that of the company.
Protek Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Protek Capital's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Protek Capital could also be used in its relative valuation, which is a method of valuing Protek Capital by comparing valuation metrics of similar companies.Protek Capital is currently under evaluation in price to sales category among its peers.
Protek Fundamentals
| Return On Asset | -0.4 | |||
| Operating Margin | 8.84 % | |||
| Current Valuation | 146.35 K | |||
| Price To Earning | (0.10) X | |||
| Price To Sales | 0.36 X | |||
| Gross Profit | 11.62 K | |||
| Net Income | (218.31 K) | |||
| Cash And Equivalents | 25.05 K | |||
| Total Debt | 84.3 K | |||
| Current Ratio | 0.03 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | 55 K | |||
| Earnings Per Share | (0) X | |||
| Beta | 101.34 | |||
| Market Capitalization | 1.46 K | |||
| Total Asset | 95.41 K | |||
| Retained Earnings | (10.24 M) | |||
| Working Capital | (641 K) | |||
| Current Liabilities | 641 K | |||
| Net Asset | 95.41 K |
About Protek Capital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protek Capital's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protek Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protek Capital based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Protek Pink Sheet
Protek Capital financial ratios help investors to determine whether Protek Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Protek with respect to the benefits of owning Protek Capital security.